electroCore Stock Price

-0.015 (-0.82%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
electroCore Inc ECOR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.015 -0.82% 1.825 10:30:15
Open Price Low Price High Price Close Price Prev Close
1.86 1.7801 1.86 1.84
Bid Price Ask Price Spread News
1.81 1.84 0.03 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
335 95,700 $ 1.82 $ 173,964 1,847,657 0.77 - 4.25
Last Trade Time Type Quantity Stock Price Currency
10:30:26 1 $ 1.825 USD

electroCore Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 82.95M 45.45M 36.54M $ 2.39M $ - -1.53 -3.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

electroCore News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ECOR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.841.95351.571.79651,654-0.015-0.82%
1 Month2.002.321.571.98995,988-0.175-8.75%
3 Months2.933.631.572.523,724,225-1.11-37.71%
6 Months1.693.631.402.452,444,3150.1357.99%
1 Year1.184.250.772.082,667,8920.64554.66%
3 Years18.0020.250.32012.201,170,835-16.18-89.86%
5 Years18.0020.250.32012.201,170,835-16.18-89.86%

electroCore Description

electroCore, Inc. is a medical device company, engaged in the commercialization and development of a platform non-invasive Vagus Nerve Stimulation ("nVNS") therapy that can be self-administered by patients. electroCore was founded in 2005 and has primarily focused on headache conditions (migraine and cluster headache). In July 2020, the U.S. Food and Drug Administration ("FDA") granted the Company an Emergency Use Authorization (EUA) authorizing the use of the Company's gammaCore Sapphire(TM) CV nVNS therapy at home or in a healthcare setting to acutely treat adult patients with known or suspected COVID-19 who are experiencing exacerbation of asthma-related dyspnea and reduced airflow, and for whom approved drug therapies are not tolerated or provide insufficient symptom relief.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.